Rapid OCD Relief: 100% of Study Patients Improved
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
Rapid OCD Relief: 100% of Study Patients Improved
-
Narrado por:
-
De:
This week on Entheo Hour, we’re breaking down the latest research on psilocybin and OCD. 🧠✨
For 40% to 60% of people living with OCD, standard SSRIs simply don't work. The brain stays locked in a cycle of intrusive thoughts and compulsive loops. But new research is pointing toward a potential breakthrough: Psilocybin.
In this breakdown, we dive into a landmark 2024 review from Pharmacological Reports that explores how psilocybin moves beyond symptom management to actually reorganize the neural pathways of the OCD-affected brain.
📚 STUDY LINK:https://pmc.ncbi.nlm.nih.gov/articles/PMC11387457/
⚠️ EDUCATIONAL CONTENT DISCLAIMER: This content discusses peer-reviewed research and legally regulated psilocybin programs in Oregon and Colorado. This information is for educational purposes only and should not be considered medical advice. Always consult with a licensed facilitator or healthcare provider regarding your specific needs.
🔗 CONNECT WITH ENTHEOGEN INSTITUTE🔹 Subscribe to Our Newsletter: https://mailchi.mp/bc97570b9ae9/subscribe-to-our-mailing-list🔹 Website: https://entheotraining.com🔹 Apply for Training: https://entheotraining.com/apply-now-1🔹 Instagram: https://www.instagram.com/entheogeninstitute🔹 LinkedIn: https://www.linkedin.com/company/entheogen-institute